Presentation ESC 2022

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies

Presenter: Michelle L. O’Donoghue

August 29, 2022

REGISTER for free or LOG IN to view this content

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies

Clinical Cardiology

Clinical Pharma

Presentation

ESC 2022

Up Next

Presentation ESC 2022

International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up

Presenter: Sripal Bangalore

August 29, 2022

More slides +

Presentation ESC 2022

FFR vs. Angiography-guided PCI in AMI with multivessel disease

Presenter: Joo-Yong Hahn

August 29, 2022

Presentation ESC 2022

Coronary Atherosclerotic Plaque Activity and Future Coronary Events

Presenter: David Newby

August 28, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.